Thursday, September 5, 2013

An Interesting Summer Indeed!

I took most of this summer off. Not because I'm too busy to write or not because there was nothing of interest to write about (on the contrary). Nope, it was because I spent most of the summer rehabbing from a very complex surgery.

The condition was described to me as an aortic dissection, which occurs when a tear in the inner wall of the aorta causes blood to flow between the layers of the wall of the aorta. Aortic dissection is a medical emergency and may lead to death rather quickly even with treatment, as a result of decreased blood supply to other organs (brain), cardiac failure, and sometimes, as in my case, rupture of the aorta. My aorta tore right as I was being hooked up to life support. Lucky timing, HooWah!


Why Am I telling you this? Two reasons, first, if you have high blood pressure make sure you treat it. It's easy and inexpensive to treat hypertension. There is a reason it's called the silent killer, cause you normally feel fine right up to when you don't, and by then it may be too late. 


Next, because of technology. Without the current technology available to the Doctors in the operating room, my chance of survival was exactly zero. There was no chance. But today, with mechanical valves, Dacron™ sleeves to replace arteries, new surgical techniques, patient monitoring systems and integrated big data (yep) this second chance becomes reality for me and tens of thousands of other patients every year.


Health care accounts for one in five dollars spent in the United States. It’s 17.9 percent of the gross domestic product, up from 4 percent in 1950. And technology has been the main driver of this spending: new drugs that cost more, new tests that find more diseases to treat, new surgical implants and techniques. Much of the spending has been worth it. While the U.S. spends the most of any country by far, health care is becoming a larger part of nearly every economy. That makes sense. Better medicine is buying longer lives. 

How does this segue into investing? Well, speaking of amazing new medical devices and technology, Vanguard has low cost Health Care ETF - (ticker symbol VHT) with a solid risk reward profile. The return since inception - after taxes on distributions - is 7.08 percent. The fund was started in 2004. The passively managed fund, which has an expense ratio of 14 basis points, tracks the performance of a benchmark index that measures the investment return of stocks in the health care sector, and holds names like Johnson & Johnson and Gilead Sciences - companies involved in providing medical or health care products, services, technology, or equipment.


Now factor in the Boomers whose first wave is already hitting the retirement years and have the money to afford procedures (elective and otherwise) and Medicare that spent $562B in 2012 and that's pretty good built in demand for medical technology and devices in my opinion.


Should everyone allocate assets to a sector fund? No, not all investors should allocate assets to this sector or any other sector for that matter. What I suggest is talking to your advisor to see if your risk profile permits any allocation and how it fits into your overall strategy. There is additional risk involved when investing in a narrow band of the stock spectrum and the potential for additional reward.


CBlakely, CFP®         09/2013





Monday, May 6, 2013

Investment Management Fees Are (Much) Higher Than You Think


I saw this is piece in a recent edition of Financial Analysts Journal, occasionally they publish a guest editorial, this one, by Charles D. Ellis, CFA is a must read if you are paying a firm to actively manage your investments. The editorial in its entirety is below.


Although some critics grouse about them, most investors have long thought that investment management fees can best be described in one word: low. Indeed, fees are seen as so low that they are almost inconsequential when choosing an investment manager. This view, however, is a delusion. Seen for what they really are, fees for active management are high—much higher than even the critics have recognized.

When stated as a percentage of assets, average fees do look low—a little over 1% of assets for individuals and a little less than one-half of 1% for institutional investors. But the investors already own those assets, so investment management fees should really be based on what investors are getting in the returns that managers produce. Calculated correctly, as a percentage of returns, fees no longer look low. Do the math. If returns average, say, 8% a year, then those same fees are not 1% or one-half of 1%. They are much higher—typically over 12% for individuals and 6% for institutions.

But even this recalculation substantially understates the real cost of active “beat the market” investment management. Here’s why: Index funds reliably produce a “commodity product” that ensures the market rate of return with no more than market risk. Index funds are now available at fees that are very small: 5 bps (0.05%) or less for institutions and 20 bps or less for individuals. Therefore, investors should consider fees charged by active managers not as a percentage of total returns but as incremental fees versus risk-adjusted incremental returns above the market index.

Thus (correctly) stated, management fees for active management are remarkably high. Incremental fees are somewhere between 50% of incremental returns and, because a majority of active managers fall short of their chosen benchmarks, infinity. And when market returns are low, as in recent years, management fees eat up even more of an investor’s return. Are any other services of any kind priced at such a high proportion of client-delivered value? Can active investment managers continue to thrive on the assumption that clients won’t figure out the reality that, compared with the readily available passive alternative, fees for active management are astonishingly high?

Fees for active management have a long and interesting history. Once upon a time, investment management was considered a “loss leader.” When pension funds first mushroomed as “fringe benefits” during the post–World War II wage-and-price freeze, most major banks agreed to manage pension fund assets as a “customer accommodation” for little or no money—that is, no explicit fee. With fixed-rate brokerage commissions, the banks exchanged commissions for cash balances in agreed proportions. The brokers got “reciprocal” commission business, and the banks got “free” balances they could lend out at prevailing interest rates. In the 1960s, a few institutional brokerage firms, including DLJ, Mitchell Hutchins, and Baker Weeks, had investment management units that charged full fees (usually 1%) but then offset those nominal fees entirely with brokerage commissions.

When the Morgan Bank took the lead in charging fees by announcing institutional fees of one quarter of 1% in the late 1960s, conventional Wall Street wisdom held that the move would cost the bank a ton of business. Actually, it lost only one account. Thus began nearly a half century of persistent fee increases, facilitated by client perceptions that fees were comfortably exceeded by incremental returns—if the right manager was chosen. Even today, despite extensive evidence to the contrary, both individual and institutional investors typically expect their chosen managers to produce significantly higher-than-market returns. That’s why fees have seemed “low.”

A relatively minor anomaly is getting more attention: While asset-based fees have increased substantially over the past 50 years—more than fourfold for both institutional and individual investors—investment results have not improved for many reasons. Changes in the equity market have been substantial, particularly in aggregate. Over the past 50 years, trading volume has increased 2,000 times—from 2 million shares a day to 4 billion—while derivatives, in value traded, have gone from zero to far more than the “cash” market. Institutional activity on the stock exchanges has gone from under 10% of trading to over 90%. And a wide array of game changers — Bloomberg, CFA charterholders, computer models, globalization, hedge funds, high-frequency trading, the internet, and so on—have become major factors in the market.

Most important, the worldwide increase in the number of highly trained professionals, all working intensely to achieve any competitive advantage, has been phenomenal. Consequently, today’s stock market is an aggregation of all the expert estimates of price-to-value coming every day from extraordinary numbers of hardworking, independent, experienced, well-informed, professional decision makers. The result is the world’s largest ever “prediction market.” Against this consensus of experts, managers of diversified portfolios of publicly traded securities who strive to beat the market are sorely challenged.

If the upward trend of fees and the downward trend of prospects for beat-the-market performance wave a warning flag for investors—as they certainly should—objective reality should cause all investors who believe investment management fees are low to reconsider.ⁱ  Seen from the right perspective, active management fees are not low— they are high, very high.

Extensive, undeniable data show that identifying in advance any one particular investment manager who will—after costs, taxes, and fees—achieve the holy grail of beating the market is highly improbable. Yes, Virginia, some managers will always beat the market, but we have no reliable way of determining in advance which managers will be the lucky ones.

Price is surely not everything, but just as surely, when analyzed as incremental fees for incremental returns, investment management fees are not “almost nothing.” No wonder increasing numbers of individual and institutional investors are turning to exchange-traded funds and index funds—and those experienced with either or both are steadily increasing their use of them.

Meanwhile, those hardworking and happy souls immersed in the fascinating complexities of active investment management might well wonder, Are we and our industry-wide compensation in a global bubble of our own creation? Does a specter of declining fees haunt our industry’s future? I believe it does, particularly for those who serve individual and institutional investors and continue to define their mission as beat-the-market performance.

Notes
ⁱ. The announcement in February by the U.S. Labor Department that it will require more disclosure of fees to 401(k) sponsors and participants may help some investors do so.

CBlakely, CFP®         05/2013